局部晚期直肠癌全新生新辅助治疗时间序贯与放射性肠炎的相关性:初步研究
本研究回顾性分析92例接受全新生新辅助治疗(TNT)的局部晚期直肠癌(LARC)患者,基于基线和放疗后T2加权MRI提取原发肿瘤区域影像组学特征,构建多时间点delta影像组学模型预测严重急性放射性肠炎(SARE)。结果显示,delta融合策略结合临床变量的SVM模型在独立测试集中AUC为0.711、灵敏度88.9%、F1评分0.696,优于基线或差值特征模型,提示多时间点影像组学有助于早期预测SARE并指导个体化TNT序贯和毒性管理。
要点
- Delta融合策略保留稳定影像组学特征,预测性能优于差值、百分比和比值定义。
- 融合delta影像组学与临床变量的SVM模型在独立测试集AUC为0.711、灵敏度88.9%。
- 多时间点MRI影像组学可早期预测TNT期间SARE,辅助个体化治疗决策。
核心结论
- 通过delta融合整合多时间点影像组学特征与临床因素,可显著改善LARC患者SARE的早期预测。
- delta融合方法优于传统delta计算,并展现出更优的预测性能。
研究设计与样本
- 回顾性分析92例接受TNT的LARC患者,所有患者均在基线(治疗前)和新辅助放疗后接受盆腔MRI。
- 从两个时间点的T2加权图像提取原发肿瘤区域影像组学特征,定义四种delta特征策略(绝对差值、百分比变化、比值和特征融合)。
- 通过统计评估和LASSO回归筛选特征,使用SVM分类器训练基线、放疗后、delta及影像组学联合临床特征模型,并在独立测试集评估性能。
主要发现
- 仅delta融合策略在特征筛选后保留稳定的影像组学特征,并在特征稳定性和模型性能上优于差值、百分比和比值定义。
- 基于delta融合影像组学联合临床变量的SVM模型预测性能和泛化能力最佳。
- 在独立测试队列中,该联合模型AUC为0.711、灵敏度为88.9%、F1评分为0.696,优于仅使用基线或delta差值特征的模型。
关键数值与推荐
- 严重急性放射性肠炎(SARE)定义为放疗前2周内基于CTCAE的症状综合评分≥3。
临床怎么用
- 多时间点MRI delta融合影像组学联合临床变量可用于LARC患者TNT期间SARE的早期预测。
- 该模型有望指导个体化TNT序贯和主动性毒性管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study aimed to develop and validate a multi-temporal magnetic resonance imaging (MRI)-based delta-radiomics model to accurately predict severe acute radiation enteritis risk in patients undergoing total neoadjuvant therapy (TNT) for locally advanced rectal cancer (LARC). METHODS: A retrospective analysis was conducted on the data from 92 patients with LARC who received TNT. All patients underwent pelvic MRI at baseline (pre-treatment) and after neoadjuvant radiotherapy (post-RT). Radiomic features of the primary tumor region were extracted from T2-weighted images at both timepoints. Four delta feature strategies were defined (absolute difference, percent change, ratio, and feature fusion) by concatenating pre- and post-RT features. Severe acute radiation enteritis (SARE) was defined as a composite CTCAE-based symptom score of ≥ 3 within the first 2 weeks of radiotherapy. Features were selected via statistical evaluation and least absolute shrinkage and selection operator regression. Support vector machine (SVM) classifiers were trained using baseline, post-RT, delta, and combined radiomic and clinical features. Model performance was evaluated in an independent test set based on the area under the curve (AUC) value and other metrics. RESULTS: Only the delta-fusion strategy retained stable radiomic features after selection, and outperformed the difference, percent, and ratio definitions in terms of feature stability and model performance. The SVM model, based on combined delta-fusion radiomics and clinical variables, demonstrated the best predictive performance and generalizability. In the independent test cohort, this combined model demonstrated an AUC value of 0.711, sensitivity of 88.9%, and F1-score of 0.696; these values surpassed those of models built with baseline-only or delta difference features. CONCLUSIONS: Integrating multi-temporal radiomic features via delta-fusion with clinical factors markedly improved early prediction of SARE in LARC. The delta-fusion approach outperformed conventional delta calculations, and demonstrated superior predictive performance. This highlights its potential in guiding individualized TNT sequencing and proactive toxicity management. CLINICAL REGISTRATION NUMBER: NA.
引用
- Ma CY, Fu Y, Liu L, et al. Radiation enteritis associated with temporal sequencing of total neoadjuvant therapy in locally advanced rectal cancer: a preliminary study. Radiat Oncol. 2025. PMID: 40739664. doi:10.1186/s13014-025-02701-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。